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Objectives: This study examines the effects of sleep restricted to four hours for three 
consecutive nights on blood parameters, known to be associated with cardiovascular risk, in 
young healthy men.
Material and methods: Eight young healthy men (age 24.5 ± 3.3 years) were studied in 
the sleep restricted group. Nine young healthy men (age 24 ± 2 years) were included in the 
control group and spent the days and nights in the sleep lab, while sleeping eight hours/night. 
One baseline night was followed by three nights of sleep restriction to four hours and by one 
recovery night of eight hours. Blood samplings were performed after the baseline night and 
after the third night of sleep restriction or without restriction for the control group.
Results: A signiﬁ  cant increase in white blood cells (WBC) (5.79 ± 1.05 vs. 6.89 ± 1.31 103 cell/μl, 
p = 0.03), and neutrophils (3.17 ± 0.69 vs 4.24 ± 0.97 103 cell/μl, p = 0.01) was observed after the 
third night of sleep restriction. Other blood parameters were not affected. No signiﬁ  cant variation 
was observed in the control group.
Conclusion: Sleep restriction affected WBC count, mainly neutrophils, considered as risk 
factor for cardiovascular disease. Stress induced by the short term sleep restriction could be 
involved in this observation.
Keywords: sleep restriction, men, cardiovascular risk, cholesterol, neutrophils
Introduction
Accumulating evidence indicates that atherosclerosis is an inﬂ  ammatory process 
involving a network of vascular cells, leukocytes, proinflammatory cytokines, 
chemoattractant cytokines (chemokines), and growth factors (Lind 2003).
In our society, many people choose to prioritise social life, leisure, professional 
activities to the detriment of sleep and voluntary reduce their sleep duration. Several 
reports indicate that a shortened sleep may be associated with an increased risk of 
morbidity, mortality (Heslop et al 2002) and hypertension (Gangwisch et al 2006). The 
mechanisms underlying these associations are not yet elucidated. A study performed 
in healthy adult subjects showed an increase in high-sensitivity C-reactive-protein 
(hs-CRP), a stable marker of inﬂ  ammation, during acute total and short term partial 
sleep deprivation (Meier-Ewert et al 2004). Recently, we observed that in postmeno-
pausal women, treated with hormonal replacement therapy, a sleep restriction to 
four hours of sleep for three consecutive nights increased white blood cells (WBC), 
monocytes, neutrophils, total cholesterol and low density lipoprotein – cholesterol 
(LDL-C) (Kerkhofs et al 2007).
Over the last several decades, an inversing number of prospective studies con-
ducted in coronary heart disease (CHD) free populations have shown a clear and 
positive correlation between the leukocyte count and risk of CHD (Zalokar et al 1981; Vascular Health and Risk Management 2008:4(6) 1468
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Grimm et al 1985; Phillips et al 1992; Kannel et al 1992; 
Gillum et al 1993). The correlation appears to persist even 
after adjustment for other risk factors (Folsom et al 1997; 
Lee et al 2001; Brown et al 2001). Other studies reported 
also correlations between other leukocytes subtypes such as 
monocyte count (Olivares et al 1993; Sweetnam et al 1997) 
and neutrophil count (Horne et al 2005).
We hypothesized that sleep restriction could activate 
inﬂ  ammatory processes and secondarily affect blood vari-
ables known to be associated with cardiovascular events and 
that a similar process could occur in young men. The current 
study examined the effect of sleep restriction to four hours 
for three consecutive nights on blood variables (inﬂ  ammatory 
markers and lipid proﬁ  le) known to be associated with an 
increased cardiovascular risk.
Material and methods
Eight young healthy nonsmoker men (age 24.5 ± 3.3 years) 
free of neurological, psychiatric, cardiac and endocrine dis-
ease participated in the partial sleep deprivation experiment 
and nine nonsmoker young healthy men aged 22–29 years 
(age 24 ± 2 years) were included in the control group. They 
had no sleep complaints and were not snoring. The presence 
of a sleep disorder was excluded on the basis of an interview 
and one night of polysomnography before inclusion in the 
study. All volunteers were not drinking alcohol on a regular 
basis and were drug-free. Their consumption of xanthine 
beverages had to be less than ﬁ  ve units/day.
The protocol was approved by the Ethics Committee at 
the Vésale Hospital. The volunteers gave written informed 
consent and received a ﬁ  nancial compensation for their 
participation in the study.
After two weeks of a regular sleep–wake schedule of 
eight hours of sleep per night documented by actigraphic 
recordings and sleep diaries, the volunteers were admitted 
to the Sleep Laboratory of the Vésale Hospital, for ﬁ  ve days 
and nights. The ﬁ  rst night was a baseline night during which 
the subjects were allowed to sleep from 11 pm to 7 am. The 
following three nights were the restriction nights during 
which sleep was allowed only between 1 am and 5 am. The 
last night was a recovery night of 8 hours (from 11 pm to 
7 am). The control group slept three consecutive nights of 
8 hours (from 11 pm to 7 am). Both groups were studied in 
similar conditions.
During the study, the subjects were under close super-
vision of the staff and performed several neurobehavioral 
tests. Continuous EEG recordings were performed with 
an ambulatory device (Medatec Pamela®) during the day 
(except between 9 am and 1 pm to allow the subjects to have 
a shower and to perform cognitive tests) and night, in order to 
control the vigilance state of the subjects and to avoid sleep 
episodes outside the permitted hours. Sleep EEG recordings 
were scored according to standard criteria (Iber et al 2007). 
The subjects received standard hospital meals of a maximum 
of 2500 calories/day with a comparable proportion of nutri-
ents (protein, fat, carbohydrate) across days and sessions. 
Controlled drinks and snacks were available during the 
restriction nights. Alcohol and xanthine derivatives (coffee, 
tea, chocolate, colas) were prohibited during the study.
The effectiveness of the sleep restriction procedure was 
conﬁ  rmed by the continuous EEG recordings.
Blood samples were obtained from an antecubital vein at 
7 am after the baseline night and after the third night of sleep 
with or without restriction. Serum samples were collected 
in vacuum tubes without anticoagulant. Plasma samples 
were harvested in citrated vacuum tubes. Whole blood was 
collected on EDTA-treated tubes. Lipids (total cholesterol, 
HDL-c, triglycerides) were measured by standardized labora-
tory techniques on a SYNCHRON LX® automate (Beckman 
Coulter), LDL cholesterol was calculated as LDL-C = total 
cholesterol – HDL cholesterol – triglycerides/5 (in mg/dl). 
Hs-CRP, ApoA and ApoB were evaluated on an Immage® 
device (Beckman). Fibrinogen was determined by the Clauss 
method on a STA® automate (Stago). Leucocytes and subsets 
were determined on a CELL-DYN4000® hemocytometer 
(Abbott).
Wilcoxon paired tests were used to compare baseline 
values to the values obtained after the third night of sleep 
restriction.
Results and discussion
Table 1 represents the values of the different blood param-
eters obtained after the baseline night and after the third night 
of sleep restriction.
A signiﬁ  cant increase in WBC and neutrophils was 
observed after the third night of sleep restriction. The other 
blood parameters were not affected. Table 2 represents 
blood parameters in the control group. No modiﬁ  cations 
were observed.
Polysomnography recordings indicated a significant 
raise in the percentage of slow wave sleep during the third 
night of sleep restriction as compared to the baseline night 
in the sleep restricted group (p = 0.008) while no signiﬁ  cant 
variation was found in the control group.
Our data indicate that a decrease in sleep duration to four 
hours for three consecutive nights signiﬁ  cantly affected WBC Vascular Health and Risk Management 2008:4(6) 1469
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counts and mainly neutrophil counts in young healthy men. 
In contrast to our previous work in postmenopausal women, 
we did not ﬁ  nd any signiﬁ  cant modiﬁ  cations in monocyte 
counts or the lipid proﬁ  le (total cholesterol, LDL). This 
difference could be attributed to the age and gender.
In addition, contrary to the study of Meier-Ewert and 
colleagues (2004), we did not observe any change in hs-CRP 
levels. This could be attributed to the shorter duration of sleep 
restriction in our study (three nights vs 10).
Interestingly, Gomez-Merino and colleagues (2005) 
reported that, in young men, three weeks of physical condition-
ing followed by ﬁ  ve days of combat course, sleep deprivation 
and physiological stress increased leukocyte and neutrophil 
counts while total lymphocytes were unchanged. Dinges and 
colleagues (1994) also observed that 64 hours of sleep depri-
vation increased neutrophil and monocyte counts. Another 
work showed that after one partial night of sleep deprivation, 
norepinephrine and epinephrine blood concentration were 
Table 1 Inﬂ  ammatory markers and lipid proﬁ  les (mean ± SD) at baseline and after the third night of sleep restriction
Variables Baseline 3rd Restriction Night Wilcoxon p values
WBC 103 cells/μl 5.79 ± 1.04 6.88 ± 1.31 0.03
Lymphocytes 103 cells/μl 2.06 ± 0.41 2.01 ± 0.31 1
Monocytes 103 cells/μl 0.51 ± 0.15 0.61 ± 0.17 0.20
Neutrophils 103 cells/μl 3.17 ± 0.69 4.24 ± 0.97 0.01
RBC 106 cells/μl 5.09 ± 0.34 5.19 ± 0.28 0.78
Fibrinogen mg/dl 2.84 ± 0.27 2.71 ± 0.12 0.46
Hs-CRP mg/dl 0.21 ± 0.24 0.20 ± 0.24 1
Cholesterol mg/dl 171.5 ± 17.64 163.24 ± 25.84 0.23
Triglycerides mg/dl 58.5 ± 17.52 68.0 ± 26.59 0.29
HDL-C mg/dl 47.5 ± 10.97 46.25 ± 10.95 0.53
LDL-C mg/dl 112.3 ± 19.47 103.4 ± 22.44 0.16
ApoA mg/dl 117.5 ± 15.63 120.13 ± 20.61 0.46
ApoB mg/dl 94.45 +12.07 89.52 ± 23.79 0.34
Abbreviations: WBC, white blood cells; RBC, red blood cells; Hs-CRP, high sensitivity C-reactive protein; LDL, low density lipoprotein; HDL, high density lipoprotein.
Notes: Conversion for lipids; Total cholesterol, HDL-C, LDL-C: 1mol/L = 38.67 mg/dl; Triglycerides: 1 mol/L = 88.57 mg/dl.
Table 2 Inﬂ  ammatory markers and lipid proﬁ  les (mean ± SD) at baseline and after the third night of sleep without restriction. 
Control group
Variables Baseline 3rd Night without 
Restriction
Wilcoxon p values
WBC 103 cells/μl 6.71 ± 0.43 6.88 ± 0.42 0.82
Lymphocytes 103 cells/μl 2.48 ± 0.41 2.47 ± 0.14 0.73
Monocytes 103 cells/μl 0.58 ± 0.03 0.53 ± 0.04 0.3
Neutrophils 103 cells/μl 3.40 ± 0.32 3.65 ± 0.35 0.1
RBC 106 cells/μl 5.31 ± 0.29 5.28 ± 0.33 0.68
Fibrinogen mg/dl 2.79 ± 0.13 2.86 ± 0.15 0.25
Hs-CRP mg/dl 0.13 ± 0.04 0.10 ± 0.02 0.25
Cholesterol mg/dl 163 ± 8.3 165 ± 8.8 0.65
Triglycerides mg/dl 68 ± 37 60 ± 29 0.54
HDL-C mg/dl 46.1 ± 2.5 45 ± 2.4 0.19
LDL-C mg/dl 103 ± 6.7 107 ± 7.9 0.49
ApoA mg/dl 124 ± 8 118 ± 8.7 0.17
ApoB mg/dl 79 ± 5.3 83 ± 5.5 0.42
Abbreviations: WBC, white blood cells; RBC, red blood cells; Hs-CRP, high sensitivity C-reactive protein; LDL, low density lipoprotein; HDL, high density lipoprotein.
Notes: Conversion for lipids; Total cholesterol, HDL-C, LDL-C: 1mol/L = 38.67 mg/dl; Triglycerides: 1 mol/L = 88.57 mg/dl.Vascular Health and Risk Management 2008:4(6) 1470
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raised (Irwin et al 1999). Interestingly, shifts in leukocyte 
have already been shown in healthy subjects after administra-
tion of epinephrine and hydrocortisone (Brohee et al 1990). 
Considering our data and all these ﬁ  ndings, we surmise that 
the stress induced by the sleep restriction could be involved 
in the observed modiﬁ  cations.
Leukocytes may inﬂ  uence the development of coronary 
heart disease through their ability to cause proteolytic and 
oxidative damage to coronary arteries. Indeed, stimulated 
neutrophils are known to: 1, secrete proteolytic proteases that 
promote the detachment of endothelial cells from vessel walls 
and the adherence of paltelets to subendothelial collagen and 
ﬁ  bronectin (Harlan et al 1981); 2, release large amounts of the 
chemotactic agent leukotriene B4 in patients with stable angina 
(Mehta et al 1989); 3, secrete large amounts of inﬂ  ammatory 
mediators (Weissman et al 1980); 4, release superoxide anions 
in hyperlipidemic patients Ludwig et al 1982).
Furthermore, Elkind and colleagues (2005) reported 
that the leukocyte count was associated with a reduced 
endothelial reactivity, furnishing a possible link with a higher 
cardiovascular risk.
Conclusion
Sleep restriction to four hours of sleep during three 
consecutive nights induced an increase in WBC counts, 
mainly neutrophils in young healthy subjects. The stress 
induced by the sleep restriction could be one mechanism 
involved. Further studies are needed to conﬁ  rm these ﬁ  ndings 
and to explore the supposed mechanisms.
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